Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2001-11-09
2002-11-05
Eyler, Yvonne (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C424S085100, C530S351000, C435S069500, C435S069520
Reexamination Certificate
active
06475741
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Technical Field
The present invention relates to an isolated, synthetic preparation of a novel neutrophil-specific chemotactic factor (NCF), monoclonal antibodies having specific binding affinity for NCF and a clone containing the complete coding sequence for NCF.
2. State of the Art
Activated monocytes/macrophages produce various mediators that cause inflammation. Among them are chemotactic factors which cause white blood cells to migrate into inflammatory sites where these factors are released. Neutrophils, the dominant leukocytes attracted by the chemotactic factors, are believed to play a critical role in the inflammatory reactions. Such diseases as rheumatoid arthritis, idiopathic pulmonary fibrosis and certain pathological inflammatory changes in many other conditions are believed to be caused by neutrophils and/or their products. However, a specific pro-inflammatory mediator released by tissue macrophages and other cells in response to inflammatory stimuli and leading to neutrophil-rich leukocyte accumulation in host defense and disease, has not heretofore been identified and isolated.
SUMMARY OF THE INVENTION
It is, therefore, an object of the present invention to provide a biologically active novel synthetic polypeptide acting as a neutrophil-specific chemotactic factor (NCF).
It is a further object of the present invention to provide a molecular clone containing the complete coding sequence for the synthesis of NCF by either prokaryotic or eukaryotic expression vectors.
It is a still further object of the present invention to provide monoclonal antibodies having specific binding affinity for NCF of the present invention.
It is another object of the present invention to provide a kit comprising a container containing the cDNA for NCF quantitation, detection or localization of NCF mRNA in a body sample.
It is yet another object of the present invention to provide a kit comprising a container containing anti-NCF antibodies having specific binding affinity for NCF for quantitation, detection or localization of NCF in a body sample.
Other objects and advantages will become evident from the following detailed description of the invention.
REFERENCES:
patent: 4714674 (1987-12-01), Palladino
patent: 4797277 (1989-01-01), Arfors
patent: 4897348 (1990-01-01), Johnson et al.
patent: 5306627 (1994-04-01), Yamada et al.
patent: 5401643 (1995-03-01), Yamada et al.
patent: 5451399 (1995-09-01), Gimbrone, Jr. et al.
patent: 5652338 (1997-07-01), Matsushima et al.
patent: 5698196 (1997-12-01), Matsushima et al.
patent: 5925352 (1999-07-01), Matsushima et al.
patent: WO 89/04325 (1989-05-01), None
patent: WO 89/04836 (1989-06-01), None
patent: WO 89/10962 (1989-11-01), None
Gregory et al., Biochemical and Biophysical Research Communications 151(2), pp. 883-90 (1988).
Walz et al., Biochemical and Biophysical Research Communications, vol. 149, No. 2, pp. 755-761 (1987).
Yoshimura et al., The Journal of Immunology, vol. 139, No. 3, pp. 788-793 (1987).
Tanaka et al., Fed. of European Biochem. Societies, vol. 236, No. 2, pp. 467-470 (1988).
Hickstein et al., Proc. Nat'l Acad. Sci. USA, vol. 86, pp. 257-261 (1989).
Schroder et al., The Journal of Immunology, vol. 139, No. 10, pp. 3474-3483 (1987).
Schmid et al., The Journal of Immunology, vol. 139, No. 1, pp. 250-256 (1987).
Yoshimura et al., Molecular Immunology, vol. 26, No. 1, pp. 87-93 (1989).
Yoshimura et al., Proc. Nat'l Acad. Sci. USA, Vol. 84, pp. 9233-9237 (1987).
Von Damme et al., J. Exp. Med., vol. 167, pp. 1364-1376 (1988).
Matsushima et al, J. Exp. Med., vol. 167, pp. 1883-1893 (1988).
Shimizu et al., Scand. J. Immunol. vol. 28, pp. 675-685 (1988).
Kownatzki, et al., Clin. Exp. Immunol., vol. 64(1), pp. 214-227 (1986).
Appella Ettore
Leonard Edward J.
Matsushima Kouji
Oppenheim Joost
Showalter Stephen D.
Andres Janet L.
Auth Dorothy R.
Eyler Yvonne
Feiler William S.
Morgan & Finnegan L.L.P.
LandOfFree
Neutrophil chemotactic factor cloned cDNA and monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neutrophil chemotactic factor cloned cDNA and monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutrophil chemotactic factor cloned cDNA and monoclonal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2982612